Nuclear Medicine

Diagnosis and Management of Lameness in the Horse

Volumn , Issue , 2003, Pages 198-212

  Ross, Mike W ^a   Stacy, Vivian S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2542597346     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-8342-3.50026-7     Document Type: Chapter

References (42)

1. 99mTc labeled phosphates as a new diagnostic aid in veterinary orthopedics. J Am Vet Radiol Soc 1977, 21:86.
2. Twardock AR A personal history of veterinary nuclear medicine. Semin Vet Med Surg (Small Anim) 1991, 6:103.
3. Devous MD, Twardock AR Techniques and applications of nuclear medicine in the diagnosis of equine lameness. J Am Vet Med Assoc 1984, 184:318.
4. Seeherman HJ, Morris E, O'Callaghan MW Comprehensive clinical evaluation of performance. Equine surgery 1992, WB Saunders, Philadelphia. J.A. Auer (Ed.).
5. Lamb CR, Koblik P Scintigraphic evaluation of skeletal disease and its application to the horse. Vet Radiol 1988, 29:16.
6. Chambers MD, Martinelli MJ, Baker GJ, et al. Nuclear medicine for diagnosis of lameness in horses. J Am Vet Med Assoc 1995, 206:792.
7. 32P] diphosphonate during endosteal healing around titanium, stainless steel and hydroxyapatite implants in rat tibial bone. Biomaterials 1995, 16:1373.
8. 99mTc-MDP accumulation mechanisms in bone. Oral Surg Oral Med Oral Pathol 1993, 75:239.
9. Shani J, Amir D, Soskolne WA, et al. Correlations between uptake of technetium, calcium, phosphate, and mineralization in rat tibial bone repair. J Nucl Med 1990, 31:2011.
10. Castronovo FP, Strauss HW Dual tracer resorption and opposition in a rat fracture model. Nucl Med Biol 1988, 15:181.
11. 32P during rat tibial bone repair. J Nucl Med 1993, 34:104.
12. Okamoto Y Accumulation of technetium-99m methylene diphosphonate: conditions affecting adsorption to hydroxapaptite. Oral Surg Oral Med Oral Pathol 1995, 80:115.
13. 99mTc-MDP uptake and histological changes during rate bone marrow regeneration. Nucl Med Biol 1988, 15:469.
14. Savelkoul TJ F, Visser WJ, Oldenburg SJ, et al. A micro-autoradiographical study of the localization of 99mTc(Sn)-MDP and 99mTc-MDP in undecalcified bone sections. Eur J Nucl Med 1986, 11:459.
15. Stokkel MP, Valdes-Olmos RA, Hoefnagel CA, et al. Tumor and therapy associated abnormal changes on bone scintigraphy: old and new phenomena. Clin Nucl Med 1993, 18:821.
16. Cheng KT, Shaw SM, Pinkerton TC, et al. A Walker 256 tumor-induced osteogenic small animal model for the evaluation of [99mTc] diphosphonate radiopharmaceuticals. Int J Nucl Med Biol 1985, 12:197.
17. Stover SM, Johnson BJ, Daft BM, et al. An association between complete and incomplete stress fractures of the humerus in racehorses. Equine Vet J 1992, 24:260.
18. Johnson B, Ardans A, Stover SM, et al. California race-horse postmortem program: a 4-year overview. Proc Am Assoc Equine Pract 1994, 40:167.
19. Stover SM, Read DH, Johnson BJ, et al. Lateral condylar fracture histomorphology in racehorses. Proc Am Assoc Equine Pract 1994, 40:173.
20. Attenburrow DP, Bowring CS, Vennart W Radioisotope bone scanning in horses. Equine Vet J 1984, 16:121.
21. Pilsworth RC Establishing a probe point counting scintigraphy system in practice. Equine Vet Educ 1996, 8:41.
22. Ross MW, Maxson AD, Stacy VS, et al. First-pass radionuclide angiography in the diagnosis of aortoiliac thromboembolism in a horse. Vet Radiol Ultrasound 1997, 38:226.
23. Bramlage LR: Personal communication, 1998.
24. Boswell R: Personal communication, 1996.
25. Seeherman HJ: Personal communication, 1992.
26. 99mtechnetium methylene disphosphonate into bone. Equine Vet J 2001, 33:591.
27. Uhlhorn H, Eksell P, Carlsten J Scintigraphic characterization of distal radial physeal closure in young Standardbred racehorses. Vet Radiol Ultrasound 2000, 41:181.
28. 99mTc-MDP uptake in exercise induced proximal phalangeal trauma in horses. Vet Radiol 1990, 31:17.
29. Ehrich PJ, Seeherman HJ, O'Callaghan MW, et al. Results of bone scintigraphy in horses used for show jumping, hunting, or eventing: 141 cases (1988-1994). J Am Vet Med Assoc 1998, 213:1460.
30. Walsh DM, Royal HD Evaluation of a single injection of 99m-labeled diethylenetriaminepentaacetic acid for measuring glomerular filtration rate in horses. Am J Vet Res 1992, 53:776.
31. Campeau RJ, Bellah RD, Varma DG K Pathologic fractures in a patient with renal osteodystrophy: failure of early detection on bone scans. Clin Nucl Med 1987, 12:510.
32. Trout DR, Hornof WJ, Liskey CC, et al. The effects of regional perineural anesthesia on soft tissue and bone phase scintigraphy in the horse. Vet Radiol 1991, 32:140.
33. Pool RR, Meagher DM Pathologic findings and pathogenesis of racetrack injuries. Vet Clin North Am Equine Pract 1990, 6:1.
34. Ross MW Scintigraphic and clinical findings in the Standardbred metatarsophalangeal joint: 114 cases (1993-1995). Equine Vet J 1998, 30:131.
35. Ross MW Observations in horses with lameness abolished by palmar digital analgesia. Proc Am Assoc Equine Pract 1998, 44:230.
36. Rabuffo T, Ross MW: Unpublished data, 2001.
37. Lanyon LE Functional strain as a determinate for bone remodeling. Calcif Tissue Int 1984, 36:S56.
38. Lanyon LE Functional strain in bone tissue as an objective and controlling stimulus for adaptive bone remodeling. J Biomech 1987, 20:1083.
39. Biewener AA Biomechanics of mammalian terrestrial locomotion. Science 1990, 250:1097.
40. Erlich PJ, Dohoo IR, O'Callaghan MW Results of bone scintigraphy in racing Standardbred horses: 64 cases (1992-1994). J Am Vet Med Assoc 1999, 215:982.
41. Davenport CL M, Ross MW Clinical relevance of abnormal scintigraphic findings in the equine pelvis: a retrospective study. Vet Surg 2001, 30:490. (abstract).
42. Morris E, Seeherman HJ, O'Callaghan MW, et al. Scintigraphic identification of skeletal muscle damage in horses 24 hours after strenuous exercise. Equine Vet J 1991, 23:347.